Healthcare

● Veeva Systems provides cloud-based software for life sciences companies, including CRM and content management tools.

● Qiagen provides molecular diagnostics and sample-technology solutions to research, clinical and applied testing customers globally.

● Dyadic's second-quarter 2026 results emphasized accelerating commercialization momentum across itsBusinessareas, including global-health collaborations.

● MiNK Therapeutics is a clinical-stage biopharmaceutical company developing allogeneic invariant natural killer T-cell therapies.

TransMedics Group (NASDAQ:TMDX) rose 2.35% to $86.27 in today's intraday trading. The maker of the Organ Care System (OCS), a portable platform that keeps donor hearts, lungs and livers functioning outside the body, has been one of the more volatile names in medical technology.

Northwest Biotherapeutics, Inc. (OTCQB:NWBO) rose 0.35% to $0.17 in today's intraday trading, a penny-stock price for this clinical-stage biotechnology company. Northwest Biotherapeutics is developing DCVax, a personalized cancer-vaccine platform, with its most advanced program aimed at glioblastoma, an aggressive form of brain cancer.

Humacyte, Inc. (NASDAQ:HUMA) rose 0.69% to $0.60 in today's intraday trading, a penny-stock price for this early-commercial biotechnology company. Humacyte develops bioengineered human tissues, most notably its acellular tissue-engineered vessel, known as Symvess, designed to be used as a replacement blood vessel in vascular …